Loans and Allowance for Credit Losses on Loans | Note 4: Loans and Allowance for Credit Losses on Loans Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their outstanding principal balances adjusted for unearned income, charge-offs, the ACL-Loans, any unamortized deferred fees or costs on originated loans and unamortized premiums or discounts on purchased loans. For loans at amortized cost, interest income is accrued based on the unpaid principal balance. The Company has made a policy election to exclude accrued interest from the amortized cost basis of loans and reports accrued interest separately from the related loan balance in the consolidated balance sheets. Accrued interest on loans totaled $42.6 million and $35.0 million at March 31, 2023 and December 31, 2022, respectively. The Company also elected not to measure an allowance for credit losses for accrued interest receivables. The accrual of interest on loans is discontinued at the time the loan is 90 days past due unless the credit is well-secured and in process of collection. Past-due status is based on contractual terms of the loan. In all cases, loans are placed on nonaccrual or charged off at an earlier date if collection of principal or interest is considered doubtful. All interest accrued but not collected for loans that are placed on nonaccrual or charged off is reversed against interest income. The interest collected on these loans is applied to the principal balance until the loan can be returned to an accrual status. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured. For all loan portfolio segments, the Company promptly charges off loans, or portions thereof, when available information confirms that specific loans are uncollectable based on information that includes, but is not limited to, (1) the deteriorating financial condition of the borrower, (2) declining collateral values, and/or (3) legal action, including bankruptcy, that impairs the borrower’s ability to adequately meet its obligations. When cash payments for accrued interest are received on nonaccrual loans in each loan class, the Company records a reduction in principle on the balance of the loan. For loan modifications, interest income is recognized on an accrual basis at the renegotiated rate if the loan is in compliance with the modified terms. The Company offers warehouse loans or credit to fund mortgage loans held for sale from closing until sale to an investor. Under a warehousing arrangement the Company funds a mortgage loan as secured financing. The warehousing arrangement is secured by the underlying mortgages and a combination of deposits, personal guarantees and advance rates. The Company typically holds the collateral until it is sent under a bailee arrangement instructing the investor to send proceeds to the Company. Typical investors are large financial institutions or government agencies. Interest earned from the time of funding to the time of sale is recognized as interest income as accrued. Fees earned agreements are recognized when collected as noninterest income. Loan Portfolio Summary Loans receivable at March 31, 2023 and December 31, 2022 include: March 31, December 31, 2023 2022 (In thousands) Mortgage warehouse lines of credit $ 604,445 $ 464,785 Residential real estate 1,215,252 1,178,401 Multi-family financing 3,566,530 3,135,535 Healthcare financing 1,941,204 1,604,341 Commercial and commercial real estate (1)(2) 1,194,320 978,661 Agricultural production and real estate 89,516 95,651 Consumer and margin loans 15,781 13,498 8,627,048 7,470,872 Less: ACL-Loans 51,838 44,014 Loans Receivable $ 8,575,210 $ 7,426,858 (1) Includes $672.9 million and $497.0 million of revolving lines of credit collateralized primarily by single-family mortgage servicing rights as of March 31, 2023 and December 31, 2022, respectively. (2) Includes only $9.1 million of non-owner occupied commercial real estate as of March 31, 2023 and included only $12.8 million as of December 31, 2022. Risk characteristics applicable to each segment of the loan portfolio are described as follows. Mortgage Warehouse Lines of Credit (MTG WHLOC): Under its warehouse program, the Company provides warehouse financing arrangements to approved mortgage companies for the origination and sale of residential mortgage loans and to a lesser extent multi-family loans. Agency eligible, governmental and jumbo residential mortgage loans that are secured by mortgages placed on existing one-to-four family dwellings may be originated or purchased and placed on each mortgage warehouse line. As a secured repurchase agreement, collateral pledged to the Company secures each individual mortgage until the lender sells the loan in the secondary market. A traditional secured warehouse line of credit typically carries a base interest rate of the Federal Reserve’s Secured Overnight Financing Rate (“SOFR”), or mortgage note rate and a margin. Risk is evident if there is a change in the fair value of mortgage loans originated by mortgage bankers in warehouse, the sale of which is the expected source of repayment of the borrowings under a warehouse line of credit. However, the warehouse customers are required to hedge the change in value of these loans to mitigate the risk. Residential Real Estate Loans (RES RE): Real estate loans are secured by owner-occupied 1- 4 family residences. Repayment of residential real estate loans is primarily dependent on the personal income and credit rating of the borrowers. First-lien HELOC mortgages included in this segment typically carry a base rate of 30-day LIBOR or the One-Year Constant Maturity Treasury (“CMT”), plus a margin. Multi-Family Financing (MF FIN): Healthcare Financing (HC FIN): The healthcare financing portfolio includes customized loan products for independent living, assisted living, memory care and skilled nursing projects. A variety of loan products are available to accommodate rehabilitation, acquisition, and refinancing of healthcare properties. Credit risk in these loans are primarily driven by local demographics and the expertise of the operators of the facilities. Repayment of these loans may include permanent loans, sales of developed property or an interim loan commitment from the Company until permanent agency-eligible financing is obtained, as well as successful operation of a business or property and the borrower’s cash flows. Loans included in this segment typically carry a base rate of SOFR that adjusts on a monthly basis and a margin. Commercial Lending and Commercial Real Estate Loans (CML & CRE): The commercial lending and commercial real estate portfolio includes loans to commercial customers for use in financing working capital needs, equipment purchases and expansions, as well as loans to commercial customers to finance land and improvements. It also includes loans collateralized by servicing rights and loan sale proceeds of mortgage warehouse customers. The loans in this category are repaid primarily from the cash flow of a borrower’s principal business operation. Credit risk in these loans is driven by creditworthiness of a borrower and the economic conditions that impact the cash flow stability from business operations. Small Business Administration (“SBA”) loans are included in this category. Less than Agricultural Production and Real Estate Loans (AG & AGRE): Agricultural production loans are generally comprised of seasonal operating lines of credit to grain farmers to plant and harvest corn and soybeans and term loans to fund the purchase of equipment. The Company also offers long term financing to purchase agricultural real estate. Specific underwriting standards have been established for agricultural-related loans including the establishment of projections for each operating year based on industry-developed estimates of farm input costs and expected commodity yields and prices. Operating lines are typically written for one year and secured by the crop and other farm assets as considered necessary. The Company is approved to sell agricultural loans in the secondary market through the Federal Agricultural Mortgage Corporation and uses this relationship to manage interest rate risk within the portfolio. Agricultural real estate loans included in this segment are typically structured with a one-year ARM, 3-year ARM or 5-year ARM CMT and a margin. Agriculture production, livestock, and equipment loans are structured with variable rates that are indexed to prime or fixed for terms not exceeding 5 years. Consumer and Margin Loans (CON & MAR): Consumer loans are those loans secured by household assets. Margin loans are those loans secured by marketable securities. The term and maximum amount for these loans are determined by considering the purpose of the loan, the margin (advance percentage against value) in all collateral, the primary source of repayment, and the borrower’s other related cash flow. ACL-Loans The Company adopted CECL on January 1, 2022. CECL replaces the previous “Allowance for Loan and Lease Losses” standard for measuring credit losses. Upon adoption of CECL, the difference in the two measurements was recorded in the ACL-Loans and retained earnings. The ACL-Loans is the Company’s estimate of expected credit losses. Loans receivable is presented net of the allowance to reflect the principal balance expected to be collected over the contractual term of the loans. This life of loan allowance is established through a provision for credit losses charged to net interest income as loans are recorded in the financial statements. The provision for a reporting period also reflects increases or decreases in the allowance related to changes in credit loss expectations. Actual credit losses are charged against the allowance when management believes the uncollectibility of a loan balance, or a portion thereof, is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ACL-Loans is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans considering relevant available information from internal and external sources, including historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral and prevailing economic conditions. The allowance also incorporates reasonable and supportable forecasts. There have been no changes to the credit quality components used to assess risk during the year ended December 31, 2022. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. The level of the ACL is believed to be adequate to absorb innate expected future losses in the loan portfolio as of the measurement date. The ACL-Loans consists of individually evaluated loans and pooled loan components. The Company’s primary portfolio segmentation is by credit risk grade. Loans risk graded substandard and worse are individually evaluated for expected credit losses. For individually evaluated loans that are collateral dependent, an allowance is established when the fair value of the collateral, the loan’s obtainable market price, or the present value of expected future cash flows discounted at the loan’s effective interest rate, is lower than the carrying value of that loan. A loan is considered to be collateral dependent when repayment is expected to be provided substantially through the operation or the sale of the collateral. To calculate the allowance for expected credit losses on loans risk graded pass through special mention, the portfolio is segmented by loans with similar risk characteristics. Loan Portfolio Segment ACL-Loans Methodology Mortgage warehouse lines of credit Remaining Life Method Residential real estate Discounted Cash Flow Multi-family financing Discounted Cash Flow Healthcare financing Discounted Cash Flow Commercial and commercial real estate Discounted Cash Flow Agricultural production and real estate Remaining Life Method Consumer and margin loans Remaining Life Method Loan characteristics used in determining the segmentation include the underlying collateral, type or purpose of the loan, and expected credit loss patterns. The estimation of expected credit losses for each segment is primarily based on historical credit loss experience. Given the Company’s modest historical credit loss experience, peer and industry data was incorporated into the measurement. Expected life of loan credit losses are quantified using discounted cash flows and remaining life methodologies. Model results are supplemented by qualitative adjustments for risk factors relevant in assessing the expected credit losses within the portfolio segments. These adjustments may increase or decrease the estimate of expected credit losses based upon the assessed level of risk for each qualitative factor. The models utilized and the applicable qualitative adjustments require assumptions and management judgment that can be subjective in nature. The above measurement approach is also used to estimate the expected credit losses associated with unfunded loan commitments, which also incorporates expected utilization rates. The following table presents, by loan portfolio segment, the activity in the ACL-Loans for the three months ended March 31, 2023 and 2022: For the Three Months Ended March 31, 2023 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,249 $ 7,029 $ 16,781 $ 9,882 $ 8,326 $ 565 $ 182 $ 44,014 Provision for credit losses 415 349 3,070 1,871 2,149 (22) (15) 7,817 Loans charged to the allowance — — — — — — — — Recoveries of loans previously charged off — — — — 7 — — 7 Balance, end of period $ 1,664 $ 7,378 $ 19,851 $ 11,753 $ 10,482 $ 543 $ 167 $ 51,838 For the Three Months Ended March 31, 2022 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,955 $ 4,170 $ 14,084 $ 4,461 $ 5,879 $ 657 $ 138 $ 31,344 Impact of adopting CECL 41 275 520 139 (1,277) (18) 21 (299) Provision for credit losses (55) 102 527 1,018 431 (42) — 1,981 Loans charged to the allowance — — — — (931) — — (931) Recoveries of loans previously charged off — — — — — — 7 7 Balance, end of period $ 1,941 $ 4,547 $ 15,131 $ 5,618 $ 4,102 $ 597 $ 166 $ 32,102 The Company recorded a total provision for credit losses of $6.9 million for the three months ended March 31, 2023. The $6.9 million total provision for credit losses consisted of $7.8 million for the ACL-Loans as shown above and $(0.9) million for the ACL-OBCE’s. The Company recorded a total provision for credit losses of $2.5 million for the three months ended March 31, 2022. The $2.5 million total provision for credit losses consisted of $2.0 million for the ACL-Loans as shown above and $0.5 million for the ACL-OBCE’s. The following table presents the allowance for loan losses and the recorded investment in loans and impairment method as of December 31, 2022: December 31, 2022 MTG WHLOC RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,955 $ 4,170 $ 14,084 $ 4,461 $ 5,879 $ 657 $ 138 $ 31,344 Impact of adopting CECL 41 275 520 139 (1,277) (18) 21 (299) Provision for credit losses (747) 2,588 2,177 5,282 4,216 (74) 31 13,473 Loans charged to the allowance — (4) — — (1,238) — (15) (1,257) Recoveries of loans previously charged off — — — — 746 — 7 753 Balance, end of period $ 1,249 $ 7,029 $ 16,781 $ 9,882 $ 8,326 $ 565 $ 182 $ 44,014 The below table presents the amortized cost basis and ACL-Loans allocated for collateral dependent loans, which are individually evaluated to determine expected credit losses: March 31, 2023 Real Estate Accounts Receivable / Equipment Other Total ACL-Loans Allocation (In thousands) RES RE $ 231 $ — $ 9 $ 240 $ 38 MF FIN 36,760 — — 36,760 184 HC FIN 21,783 — — 21,783 132 CML & CRE — 4,986 1,493 6,479 1,381 AG & AGRE 147 — — 147 1 CON & MAR — — 5 5 — Total collateral dependent loans $ 58,921 $ 4,986 $ 1,507 $ 65,414 $ 1,736 There have been no significant changes to the types of collateral securing the Company’s collateral dependent loans compared to March 31, 2022. Internal Risk Categories In adherence with policy, the Company uses the following internal risk grading categories and definitions for loans: Pass Special Mention (Watch) – This is a loan that is sound and collectable but contains potential risk. Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution’s credit position at some future date. Substandard Doubtful The following tables present the credit risk profile of the Company’s loan portfolio based on internal risk rating category as of March 31, 2023 and December 31, 2022: As of March 31, 2023 2023 2022 2021 2020 2019 Prior Revolving Loans TOTAL (In thousands) MTG WHLOC Pass $ — $ — $ — $ — $ — $ — $ 604,445 $ 604,445 Total $ — $ — $ — $ — $ — $ — $ 604,445 $ 604,445 RES RE Pass 3,207 13,097 8,339 24,856 3,475 12,867 1,148,709 1,214,550 Special Mention (Watch) — — — — 60 402 — 462 Substandard — — — — — 240 — 240 Total $ 3,207 $ 13,097 $ 8,339 $ 24,856 $ 3,535 $ 13,509 $ 1,148,709 $ 1,215,252 MF FIN Pass 382,298 1,221,448 494,235 156,813 32,201 11,347 1,159,249 3,457,591 Special Mention (Watch) — 32,807 16,379 8,000 — — 14,993 72,179 Substandard — 36,760 — — — — — 36,760 Total $ 382,298 $ 1,291,015 $ 510,614 $ 164,813 $ 32,201 $ 11,347 $ 1,174,242 $ 3,566,530 HC FIN Pass 93,837 1,176,484 265,032 79,805 13,682 — 207,521 1,836,361 Special Mention (Watch) 22,709 22,437 29,014 — — — 8,900 83,060 Substandard — — 21,783 — — — — 21,783 Total $ 116,546 $ 1,198,921 $ 315,829 $ 79,805 $ 13,682 $ — $ 216,421 $ 1,941,204 CML & CRE Pass 23,150 130,905 85,065 22,411 22,109 19,553 881,494 1,184,687 Special Mention (Watch) 17 41 473 1,103 116 323 1,081 3,154 Substandard — 496 2,057 586 70 632 2,638 6,479 Total $ 23,167 $ 131,442 $ 87,595 $ 24,100 $ 22,295 $ 20,508 $ 885,213 $ 1,194,320 AG & AGRE Pass 4,439 11,116 7,163 15,049 5,675 20,352 24,124 87,918 Special Mention (Watch) — 14 54 462 344 551 26 1,451 Substandard — — — — — 147 — 147 Total $ 4,439 $ 11,130 $ 7,217 $ 15,511 $ 6,019 $ 21,050 $ 24,150 $ 89,516 CON & MAR Pass 137 4,570 403 220 62 4,502 5,861 15,755 Special Mention (Watch) — — — 19 — 2 — 21 Substandard — — — — — 5 — 5 Total $ 137 $ 4,570 $ 403 $ 239 $ 62 $ 4,509 $ 5,861 $ 15,781 Total Pass $ 507,068 $ 2,557,620 $ 860,237 $ 299,154 $ 77,204 $ 68,621 $ 4,031,403 $ 8,401,307 Total Special Mention (Watch) $ 22,726 $ 55,299 $ 45,920 $ 9,584 $ 520 $ 1,278 $ 25,000 $ 160,327 Total Substandard $ — $ 37,256 $ 23,840 $ 586 $ 70 $ 1,024 $ 2,638 $ 65,414 Total Loans $ 529,794 $ 2,650,175 $ 929,997 $ 309,324 $ 77,794 $ 70,923 $ 4,059,041 $ 8,627,048 Total Charge offs $ — $ — $ — $ — $ — $ — $ — $ — December 31, 2022 2022 2021 2020 2019 2018 Prior Revolving Loans TOTAL (In thousands) MTG WHLOC Pass $ — $ — $ — $ — $ — $ — $ 464,785 $ 464,785 Total $ — $ — $ — $ — $ — $ — $ 464,785 $ 464,785 RES RE Pass 13,344 8,192 24,708 3,498 1,722 11,166 1,114,705 1,177,335 Special Mention (Watch) — — — 61 — 668 91 820 Substandard — — — — 74 172 — 246 Total $ 13,344 $ 8,192 $ 24,708 $ 3,559 $ 1,796 $ 12,006 $ 1,114,796 $ 1,178,401 MF FIN Pass 1,212,008 544,823 200,829 32,349 4,416 7,229 1,042,024 3,043,678 Special Mention (Watch) 32,919 — 8,000 — — — 14,178 55,097 Substandard 36,760 — — — — — — 36,760 Total $ 1,281,687 $ 544,823 $ 208,829 $ 32,349 $ 4,416 $ 7,229 $ 1,056,202 $ 3,135,535 HC FIN Pass 987,676 301,103 78,792 13,770 — — 123,888 1,505,229 Special Mention (Watch) 52,022 25,307 — — — — — 77,329 Substandard — 21,783 — — — — — 21,783 Total $ 1,039,698 $ 348,193 $ 78,792 $ 13,770 $ — $ — $ 123,888 $ 1,604,341 CML & CRE Pass 123,757 86,282 23,803 24,730 12,335 8,765 690,114 969,786 Special Mention (Watch) 43 164 963 119 99 228 1,376 2,992 Substandard — 2,017 591 72 — 666 2,537 5,883 Total $ 123,800 $ 88,463 $ 25,357 $ 24,921 $ 12,434 $ 9,659 $ 694,027 $ 978,661 AG & AGRE Pass 12,112 7,485 15,660 5,808 3,137 20,176 29,566 93,944 Special Mention (Watch) 14 55 462 421 163 389 56 1,560 Substandard — — — — — 147 — 147 Total $ 12,126 $ 7,540 $ 16,122 $ 6,229 $ 3,300 $ 20,712 $ 29,622 $ 95,651 CON & MAR Pass 4,673 463 307 101 4,589 9 3,328 13,470 Special Mention (Watch) — — 20 — — 2 — 22 Substandard — — — — — 6 — 6 Total $ 4,673 $ 463 $ 327 $ 101 $ 4,589 $ 17 $ 3,328 $ 13,498 Total Pass $ 2,353,570 $ 948,348 $ 344,099 $ 80,256 $ 26,199 $ 47,345 $ 3,468,410 $ 7,268,227 Total Special Mention (Watch) $ 84,998 $ 25,526 $ 9,445 $ 601 $ 262 $ 1,287 $ 15,701 $ 137,820 Total Substandard $ 36,760 $ 23,800 $ 591 $ 72 $ 74 $ 991 $ 2,537 $ 64,825 Total Loans $ 2,475,328 $ 997,674 $ 354,135 $ 80,929 $ 26,535 $ 49,623 $ 3,486,648 $ 7,470,872 The Company did not have any material revolving loans converted to term loans at March 31, 2023 or December 31, 2022. The Company evaluates the loan risk grading system definitions and ACL-Loans methodology on an ongoing basis. No significant changes were made to either during the past year. Delinquent Loans The following tables present the Company’s loan portfolio aging analysis of the recorded investment in loans as of March 31, 2023 and December 31, 2022. March 31, 2023 30-59 Days 60-89 Days Greater Than Total Total Past Due Past Due 90 Days Past Due Current Loans (In thousands) MTG WHLOC $ — $ — $ — $ — $ 604,445 $ 604,445 RES RE 2,573 2,409 918 5,900 1,209,352 1,215,252 MF FIN — 12,975 36,760 49,735 3,516,795 3,566,530 HC FIN — — 21,783 21,783 1,919,421 1,941,204 CML & CRE 209 495 3,778 4,482 1,189,838 1,194,320 AG & AGRE 236 43 1,242 1,521 87,995 89,516 CON & MAR 47 1 22 70 15,711 15,781 $ 3,065 $ 15,923 $ 64,503 $ 83,491 $ 8,543,557 $ 8,627,048 December 31, 2022 30-59 Days 60-89 Days Greater Than Total Total Past Due Past Due 90 Days Past Due Current Loans (In thousands) MTG WHLOC $ — $ — $ — $ — $ 464,785 $ 464,785 RES RE 4,053 152 272 4,477 1,173,924 1,178,401 MF FIN — — — — 3,135,535 3,135,535 HC FIN — — 21,783 21,783 1,582,558 1,604,341 CML & CRE 4,759 — 3,778 8,537 970,124 978,661 AG & AGRE 4,903 — — 4,903 90,748 95,651 CON & MAR 6 24 22 52 13,446 13,498 $ 13,721 $ 176 $ 25,855 $ 39,752 $ 7,431,120 $ 7,470,872 Nonperforming Loans Nonaccrual loans, including modified loans that have not met the six-month minimum performance criterion, are reported as nonperforming loans. For all loan classes, it is the Company’s policy to have any restructured loans which are on nonaccrual status prior to being restructured remain on nonaccrual status until three months of satisfactory borrower performance, at which time management would consider its return to accrual status. A loan is generally classified as nonaccrual when the Company believes that receipt of principal and interest is doubtful under the terms of the loan agreement. Generally, this is at 90 or more days past due. The amount of interest income recognized on nonaccrual financial assets during the year ended March 31, 2023 was immaterial. The following table presents the Company’s nonaccrual loans and loans past due 90 days or more and still accruing at March 31, 2023 and December 31, 2022. March 31, December 31, 2023 2022 Total Loans > Total Loans > 90 Days & 90 Days & Nonaccrual Accruing Nonaccrual Accruing (In thousands) RES RE $ 240 $ 741 $ 245 $ 96 MF FIN 36,760 — — — HC FIN 21,783 — 21,783 — CML & CRE 4,357 — 4,390 — AG & AGRE 147 1,242 147 — CON & MAR 5 17 6 16 $ 63,292 $ 2,000 $ 26,571 $ 112 The Company did not have any nonperforming loans without an estimated ACL at March 31, 2023. On January 1, 2023, the Company adopted FASB Accounting Standards Update (ASU) No. 2022-02, Financial Instruments – Credit Losses (Topic 326) Troubled Debt Restructurings and Vintage Disclosures. The Company adopted the prospective approach for this new guidance. During the three months ended March 31, 2023, there was one customer experiencing financial difficulty that was modified from the original contractual terms to a delayed payment schedule. The following table presents the Company’s modified loans during the three months ended March 31, 2023. For the Three Months Ended March 31, 2023 Principal Forgiveness Payment Delay Term Extension Interest Rate Reduction Combination Term Extension and Principal Forgiveness Combination Term Extension Interest Rate Reduction Total Class of Financing Receivable (In thousands) Commercial and commercial real estate $ — $ 4,357 $ — $ — $ — $ — — % Total $ — $ 4,357 $ — $ — $ — $ — — % residential loans in the process of foreclosure as of March 31, 2023 and December 31, 2022. Loans Purchased The Company purchased $98.8 million and $40.7 million of loans during the three months ended March 31, 2023 and 2022, respectively. |